Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - donepezil hydrochloride - film coated tablet - 5 milligram - anticholinesterases

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing - donepezil hydrochloride - film coated tablet - 10 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

b & s healthcare - donepezil hydrochloride - film coated tablet - 10 milligram

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

eisai (malaysia) sdn bhd (18039-d) - donepezil hcl -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

eisai (malaysia) sdn bhd (18039-d) - donepezil hcl -

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - donepezil hydrochloride 10mg - orodispersible tablet - 10 mg - active: donepezil hydrochloride 10mg excipient: carrageenan colloidal silicon dioxide iron oxide yellow mannitol polyvinyl alcohol - aricept is indicated for the treatment of mild, moderate and severe alzheimer's disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - donepezil hydrochloride 5mg - orodispersible tablet - 5 mg - active: donepezil hydrochloride 5mg excipient: carrageenan colloidal silicon dioxide mannitol polyvinyl alcohol - aricept is indicated for the treatment of mild, moderate and severe alzheimer's disease.

Ireland - English - HPRA (Health Products Regulatory Authority)

clear pharmacy - donepezil hydrochloride - film coated tablet - 10 milligram - anticholinesterases

Ireland - English - HPRA (Health Products Regulatory Authority)

clear pharmacy - donepezil hydrochloride - film coated tablet - 5 milligram - anticholinesterases

United States - English - NLM (National Library of Medicine)

eisai inc. - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - solution - 1 mg in 1 ml - aricept® is indicated for the treatment of dementia of the alzheimer's type. efficacy has been demonstrated in patients with mild to moderate alzheimer's disease, as well as in patients with severe alzheimer's disease. aricept® is contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives.